Showing results (1881-1890 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|November 26, 2009
Consolidation with high-dose chemotherapy and stem cell support for responding patients with metastatic soft tissue sarcomas: prospective, single-institutional phase II studyB Kasper, I Scharrenbroich, T Schmitt, et al.Bone Marrow Transplantation|June 3, 2025
Prolonged length of stay in high-risk patients undergoing allogeneic stem cell transplantation: a call to action for addressing healthcare challengesAyman Sayyed, Igor Novitzky-Basso, Mats Remberger, et al.Bone Marrow Transplantation|May 27, 2025
Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the SAAWP EBMTJuan Montoro, Dirk-Jan Eikema, Brian Piepenbroek, et al.Bone Marrow Transplantation|July 17, 2025
Characteristics and prognosis of central nervous system relapse after allogeneic hematopoietic stem cell transplantation in adult patients with leukemiaLi-Ping Guo, Li-Juan Hu, Xiao-Dong Mo, et al.Bone Marrow Transplantation|July 3, 2025
Impact of pre-transplant induction cycles on post-transplant outcomes in patients with ALL: a study from the ALWP EBMTJuan Montoro, Allain-Thibeault Ferhat, Nathalie Dhedin, et al.Bone Marrow Transplantation|December 24, 2025
The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutationsIman Abou Dalle, Jacques-Emmanuel Galimard, Xavier Poire, et al.Bone Marrow Transplantation|April 29, 2025
Outcomes of human leukocyte antigen matched sibling transplant from consanguineous versus non-consanguineous parents, a single center experienceRiad El Fakih, Mohamed I Sharif, Shaykhah Alotaibi, et al.Bone Marrow Transplantation|April 14, 2025
Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter surveyNiklas Brehm, Francesca Biavasco, Johannes Clausen, et al.Bone Marrow Transplantation|April 13, 2025
Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemiasAbdullah Karakus, Tayfur Toptas, Mehmet Sinan Dal, et al.Bone Marrow Transplantation|April 9, 2025
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines CommitteeGuillermo Ortí, Guillaume Dachy, Charlotte E Graham, et al.Pageof 993